Severe Feeding Difficulties – Failure to Thrive – Microcephaly due to ASXL3 Deficiency

Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Patient Mode

Understand this article easily

Switch between simple English and easy Bangla patient notes. This is for education and does not replace a doctor consultation.

Severe feeding difficulties – failure to thrive – microcephaly due to ASXL3 deficiency (Bainbridge-Ropers/ASXL3-related disorder) is a rare genetic neurodevelopmental condition caused by loss-of-function variants in the ASXL3 gene. Most children have moderate-to-severe developmental delay, very limited speech, hypotonia (low muscle tone), feeding problems starting...

For severe symptoms, danger signs, pregnancy, child illness, or sudden worsening, seek urgent medical care.

বাংলা রোগী নোট এখনো যোগ করা হয়নি। পোস্ট এডিটরে “RX Bangla Patient Mode” বক্স থেকে সহজ বাংলা সারাংশ যোগ করুন।

এই তথ্য শিক্ষা ও সচেতনতার জন্য। এটি ডাক্তারি পরীক্ষা, রোগ নির্ণয় বা প্রেসক্রিপশনের বিকল্প নয়।

Article Summary

Severe feeding difficulties – failure to thrive – microcephaly due to ASXL3 deficiency (Bainbridge-Ropers/ASXL3-related disorder) is a rare genetic neurodevelopmental condition caused by loss-of-function variants in the ASXL3 gene. Most children have moderate-to-severe developmental delay, very limited speech, hypotonia (low muscle tone), feeding problems starting in infancy, poor growth (failure to thrive), and often microcephaly (small head size). Many show autistic features, sleep problems, reflux,...

Key Takeaways

  • This article explains Other names in simple medical language.
  • This article explains Types in simple medical language.
  • This article explains Causes in simple medical language.
  • This article explains Common symptoms and signs in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Severe symptoms, breathing difficulty, fainting, confusion, or rapidly worsening illness.
  • New weakness, severe pain, high fever, or symptoms after a serious injury.
  • Any symptom that feels urgent, unusual, or unsafe for the patient.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.
Definition

Severe feeding difficulties – failure to thrive – microcephaly due to ASXL3 deficiency (Bainbridge-Ropers/ASXL3-related disorder) is a rare genetic neurodevelopmental condition caused by loss-of-function variants in the ASXL3 gene. Most children have moderate-to-severe developmental delay, very limited speech, hypotonia (low muscle tone), feeding problems starting in infancy, poor growth (failure to thrive), and often microcephaly (small head size). Many show autistic features, sleep problems, reflux, constipation, and a broad set of day-to-day care needs. There is no “cure” drug today; care focuses on nutrition, feeding safety, growth, sleep, mobility, behavior, and family support using a coordinated team. Genetic Diseases Info Center+3NCBI+3Orpha+3 Low tone and oral-motor discoordination make sucking, chewing, and swallowing inefficient. Reflux and constipation are common and can reduce intake. Sensory issues and learned aversions can add to the challenge. This mix raises the risk of malnutrition and aspiration, so early, structured feeding assessment and nutrition support are essential. NCBI+1

ASXL3 deficiency syndrome is a genetic neurodevelopmental disorder in which a change in the ASXL3 gene disrupts normal control of other genes during growth and brain development. Children often have global developmental delay, very limited speech, low muscle tone (hypotonia), feeding problems from infancy, poor weight gain (failure to thrive), and small head size (microcephaly). Many also have distinct but subtle facial features and may show autistic traits or other behavioral differences. The condition is usually recognized in infancy or early childhood when feeding and developmental concerns appear. NCBI+2PubMed+2

ASXL3 works like a “gene activity organizer” that helps switch many other genes on and off at the right time. When one copy is damaged, the balance is thrown off (called haploinsufficiency). That imbalance can disturb body growth, brain wiring, and muscle tone. Because ASXL3 touches many gene networks, symptoms vary from child to child, but feeding difficulty, growth failure, and microcephaly are common threads. GeneCards+1


Other names

  • ASXL3-related disorder (GeneReviews/GARD) NCBI+1

  • Bainbridge–Ropers syndrome (BRPS) (OMIM/Orphanet, medical papers) Orpha+1

  • Severe feeding difficulties–failure to thrive–microcephaly due to ASXL3 deficiency (Orphanet disease label) Orpha

These names all describe the same disorder caused by damaging variants in ASXL3. Orpha


Types

There is no formal set of medical “types,” but doctors sometimes group cases by features that help with counseling and care:

  1. Classic ASXL3/BRPS pattern. Clear feeding problems from infancy, poor growth, microcephaly, hypotonia, significant speech delay, and global developmental delay. This is the most typical presentation described in early reports. Nature+1

  2. Severity spectrum. Some children are more severely affected (earlier feeding tube, profound speech impairment); others are milder (better growth catch-up, limited words). The range likely reflects where the genetic change sits and how much ASXL3 function remains. ScienceDirect

  3. Mutation-cluster related differences. Many pathogenic variants sit in two mutational cluster regions (MCRs) of the gene. Research suggests location may influence features, but this is still being studied. ScienceDirect

  4. Mosaic or inherited cases. Very rarely, a parent may have mosaicism (the variant is present in some cells only) and can pass it on. This matters for family planning and recurrence risk. Frontiers


Causes

Below are 20 causes/contributors that explain why children with ASXL3 deficiency develop severe feeding difficulties, failure to thrive, and microcephaly. Each item reflects either the genetic root cause or a biologic/clinical mechanism commonly seen in this syndrome.

  1. ASXL3 loss-of-function variant. Truncating or otherwise damaging changes remove one working copy; this is the fundamental cause. Nature

  2. Haploinsufficiency. One working copy is not enough to maintain normal gene regulation. search.clinicalgenome.org

  3. Disrupted chromatin regulation. ASXL3 helps organize how DNA folds and how genes are turned on/off; disruption affects many tissues. GeneCards

  4. Generalized hypotonia. Low muscle tone weakens suck and swallow, making feeding slow and tiring. PubMed

  5. Oral–pharyngeal dyscoordination. Neuromotor delay can impair the complex timing of swallowing, raising choking/aspiration risk. (Inferred mechanism in neurodevelopmental disorders with hypotonia.) NCBI

  6. Gastroesophageal reflux (GER/GERD). Reflux can worsen poor intake and discomfort, further limiting weight gain. (Frequently noted in clinical series.) National Organization for Rare Disorders

  7. Feeding aversion. Early negative experiences (e.g., choking, reflux pain) can lead to refusal and limited diet. (Common in neurodevelopmental feeding disorders.) National Organization for Rare Disorders

  8. Increased energy needs from abnormal tone or movement. Some children have movement patterns that raise energy use; if intake is low, weight falters. (General pediatric nutrition principle applied to ASXL3.) NCBI

  9. Delayed gastric emptying/constipation. GI motility issues can reduce appetite and intake. (Reported across ASXL-related cohorts and rare disease resources.) National Organization for Rare Disorders

  10. Sleep disturbance. Poor sleep can worsen daytime feeding and growth. (Behavioral differences/sleep problems are common in BRPS.) National Organization for Rare Disorders

  11. Seizures (in a subset). Seizures can affect feeding safety and stamina when present. (Described in case series and reviews.) Cureus

  12. Microcephaly itself. Small head size reflects altered brain growth, which co-travels with motor/sensory feeding issues. PubMed

  13. Structural brain differences. Some children show delayed myelination or other MRI changes that correlate with global delays. BioMed Central

  14. Subtle craniofacial features. Jaw or palate shape can influence latch and chew efficiency even when changes are mild. (Dysmorphic features commonly reported.) Nature

  15. Autistic traits/sensory challenges. Sensory sensitivity can limit textures accepted, narrowing intake. NCBI

  16. Frequent infections in some children. Illness reduces appetite and increases needs, pushing weight gain down. (General pediatric effect; noted in case reports.) BioMed Central

  17. Feeding tube complications (when used). Tubes save lives but can also cause reflux/irritation that need management. (Clinical care reality; registry efforts track this.) ClinicalTrials.gov

  18. Medication side effects. Drugs for reflux, seizures, or behavior may alter appetite or GI motility in some children. (General pediatric pharmacology, applied in BRPS care.) NCBI

  19. Delayed oral-motor skill acquisition. Late transition to solids lowers calorie density and growth. (Developmental mechanism in hypotonia.) NCBI

  20. Psychosocial stress on feeding routines. High caregiver stress and complex schedules can unintentionally reduce feeding opportunities without structured plans. (Observed across rare neurodevelopmental disorders; natural history studies address caregiver support.) ClinicalTrials.gov


Common symptoms and signs

  1. Severe feeding difficulties in infancy. Babies may struggle to latch, suck, or coordinate swallowing, leading to long feeds, choking, or poor intake. Tube feeding is sometimes needed for safety and growth. Nature+1

  2. Failure to thrive (poor weight gain). Despite careful feeding, weight and length may fall below growth curves without calorie-dense plans or tube support. PubMed

  3. Microcephaly (small head size). Head circumference is smaller than expected for age and sex, reflecting altered brain growth. Orpha

  4. Global developmental delay. Rolling, sitting, walking, and self-help skills appear later than typical. NCBI

  5. Severe speech delay or absent speech. Many children use few or no words; alternative communication is important. NCBI

  6. Hypotonia (low muscle tone). Feels “floppy” in infancy; affects posture, feeding, and mobility. PubMed

  7. Behavioral differences/autistic traits. Social communication differences, sensory sensitivities, and repetitive behaviors may occur. NCBI

  8. Distinct facial features. Features are often subtle but may include high arched eyebrows, thin upper lip, and other minor traits noted by geneticists. Nature

  9. Sleep problems. Trouble falling or staying asleep is commonly reported and affects daytime function. National Organization for Rare Disorders

  10. Reflux and GI symptoms. Vomiting, irritability with feeds, and constipation can be ongoing challenges. National Organization for Rare Disorders

  11. Seizures (in some). Not universal, but recognized; EEG is done if spells or regressions occur. Cureus

  12. Minor skeletal findings. Some reports describe ulnar deviation of hands or other subtle skeletal changes. Nature

  13. Motor incoordination. Unsteady movements and fine-motor delays are frequent because of hypotonia and developmental delay. PubMed

  14. Recurrent infections. Some children experience frequent colds or chest infections, which can worsen feeding and growth. (Described in case reports.) BioMed Central

  15. Learning disability/intellectual disability. Usually moderate to severe; education plans and therapies are essential. NCBI


How doctors diagnose this condition

Key point: Because clinical signs overlap with other conditions, genetic testing is the most reliable way to diagnose ASXL3-related disorder. Doctors confirm it by finding a pathogenic variant in ASXL3 using modern DNA tests. Supportive tests help measure nutrition, safety, and development. NCBI

A) Physical examination

  1. Growth measurements. Weight, length/height, and head circumference are plotted over time to spot failure to thrive and microcephaly. Serial measurements show trends and response to care. Orpha

  2. Neurologic tone and reflexes. Checking for hypotonia, head control, and primitive reflex patterns guides therapy plans and swallow safety. PubMed

  3. Dysmorphology assessment. A clinical geneticist examines facial features, hands, and other minor anomalies that, together with history, raise suspicion for ASXL3-related disorder. Nature

  4. Feeding observation. Watching a real-time feed (positioning, latch, endurance, choking/cough) often reveals the main barriers to intake. NCBI

  5. Behavioral/communication screening. Simple tools and interview questions identify autistic traits, sensory sensitivities, and sleep issues that influence care. NCBI

B) Manual/bedside tests

  1. Bedside swallow assessment (SLP). A speech-language pathologist evaluates oral-motor skills, secretion control, and signs of aspiration to decide if instrumental studies are needed. NCBI

  2. 24-hour feeding diary/observation. Tracking volumes, time per feed, emesis, and discomfort helps tailor calorie density and schedules. National Organization for Rare Disorders

  3. Developmental testing (e.g., Bayley or similar). Hands-on play-based assessments estimate cognitive, language, and motor levels to plan therapies. NCBI

  4. Nutritional assessment by dietitian. Calorie counts, texture tolerance, and micronutrient intake are reviewed; supplements or tube strategies are proposed. National Organization for Rare Disorders

  5. Sleep diary/behavioral logs. Patterns guide behavioral and medical strategies to improve rest and daytime feeding. National Organization for Rare Disorders

C) Laboratory and pathological tests

  1. Basic labs for growth faltering. CBC, electrolytes, liver/kidney function, ferritin/iron, and vitamin D check for treatable contributors to poor growth. (Supportive screening used in failure-to-thrive workups.) NCBI

  2. Thyroid function tests. thyroid gland makes too little hormone. সহজ বাংলা: থাইরয়েড হরমোন কম।" data-rx-term="hypothyroidism" data-rx-definition="Hypothyroidism means the thyroid gland makes too little hormone. সহজ বাংলা: থাইরয়েড হরমোন কম।">Hypothyroidism can worsen hypotonia and growth; doctors rule it out. (General failure-to-thrive evaluation principle.) NCBI

  3. Celiac serology (if symptoms suggest). Malabsorption can mimic or compound poor growth and feeding distress. (Standard pediatric FTT workup when indicated.) NCBI

  4. Genetic testing – chromosomal microarray. First-tier screen for large deletions/duplications that might point to ASXL3 or other conditions. NCBI

  5. Genetic testing – ASXL3 sequencing/exome/genome. The diagnostic test: identifies a pathogenic ASXL3 variant; parental testing checks if it is de novo or inherited mosaic. NCBI+1

D) Electrodiagnostic tests

  1. EEG (if seizures or concerning spells). Looks for epileptiform activity to guide antiseizure treatment. Seizures are reported in a subset. Cureus

  2. Video-EEG (when spells are unclear). Combines brain waves with video to match events and tailor therapy. Cureus

  3. ECG (case-by-case). Used if medications or symptoms raise concern for rhythm effects; not routine for ASXL3 itself but part of safe comprehensive care. NCBI

E) Imaging tests

  1. Brain MRI. Some children show delayed myelination or other nonspecific changes that align with global developmental delay; MRI also rules out other causes. BioMed Central

  2. Videofluoroscopic swallow study (VFSS). Moving X-ray during swallowing detects aspiration and guides decisions on thickness, pacing, or need for temporary tube feeding. NCBI

Non-pharmacological treatments (therapies & others)

Below are 10 high-yield, first-line non-drug approaches. I can expand to 20 with 150-word paragraphs each on request.

1) Multidisciplinary feeding team care. A coordinated program (pediatrics, gastroenterology, dietetics, SLP/OT, psychology) screens the four domains of pediatric feeding disorder—medical, nutrition, feeding skills, psychosocial—and builds a stepwise plan (positioning, pacing, textures, caregiver coaching). Team care improves safety and growth and reduces hospital use. NCBI+1

2) Structured mealtime routines & responsive feeding. Short, predictable meals; hunger-satiety cues; no force-feeding; positive reinforcement; caregiver modeling; and gradual exposure reduce aversion and improve intake quality. NCBI+1

3) Swallow/airway safety interventions. Formal swallow study (as indicated), upright posture, chin-tuck, pacing, and flow-controlled nipples can lower aspiration risk while skills develop. NCBI

4) Texture and flow modification. Thickened liquids (as clinically indicated), purées/soft solids, and careful progression to mixed textures can match oral-motor ability and reduce coughing and distress. NCBI

5) High-calorie nutrition strategies. Energy-dense formulas/foods, modular calorie boosters, and planned snacks target catch-up growth while limiting mealtime fatigue. Registered dietitians track weight-for-length/BMI and micronutrients. NCBI

6) Reflux-reducing positioning & meal hygiene. Smaller, frequent feeds; upright after meals; head-of-bed elevation; and avoiding late heavy feeds may reduce symptoms alongside or before medicines. Medscape+1

7) Oral-motor therapy (SLP/OT). Cheek/lip/tongue strength, rhythm, and coordination training; desensitization for gag/sensory issues; and caregiver home programs support safer, more efficient eating. NCBI

8) Constipation prevention program. Fiber/water plan, routine toilet sitting, and activity improve stooling; this often improves appetite and reflux triggers. NCBI

9) Sleep hygiene program. Fixed schedule, light in morning/dark evenings, screen curfew, calming routine, and environment optimization are first-line for sleep issues common in neurodevelopmental disorders. BioMed Central

10) Caregiver training & psychosocial support. Coaching reduces stress, improves adherence, and sustains gains; psychosocial support addresses mealtime anxiety and family burden. NCBI


Drug treatments

Below are 10 evidence-based, commonly used medications tied to real problems (reflux, constipation, sleep, seizures, sialorrhea, spasticity). Doses are typical pediatric ranges and must be individualized by the child’s clinicians.

1) Omeprazole (PPI) for GERD. Class: Proton pump inhibitor. Typical dose/time: ~0.7–3.5 mg/kg/day once daily (some split BID) before breakfast. Purpose: Reduce acid to ease pain/esophagitis that worsens feeding. Mechanism: Irreversibly blocks H+/K+ ATPase in parietal cells, lowering gastric acid. Side effects: pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">Headache, diarrhea/constipation, potential infection risk with prolonged use; long-term monitoring needed. PubMed Central+1

2) Lansoprazole (PPI) for GERD. Class: PPI. Dose/time: ~1–2 mg/kg/day once daily (some BID), before meals. Purpose/mechanism/risks: As above; alternative formulation can help in children needing dispersible forms. PubMed Central

3) Famotidine for reflux symptoms. Class: H2 receptor blocker. Dose/time: ~0.5–1 mg/kg/dose BID. Purpose: Symptom relief where PPI not indicated or as bridge. Mechanism: Blocks H2 receptors on parietal cells to reduce acid; Side effects: pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">Headache, tolerance with prolonged use. PubMed Central

4) Alginate-based raft agents (e.g., sodium alginate). Class: Barrier/raft antacid. Dose/time: Product-specific; after feeds/at bedtime. Purpose: Mechanical barrier to post-prandial reflux. Mechanism: Forms viscous “raft” floating on gastric contents. Side effects: Constipation/diarrhea, sodium load in some products. PubMed Central

5) Baclofen (for reflux & spasticity). Class: GABA_B agonist antispasticity agent. Dose/time: ~0.25–0.5 mg/kg/dose TID (spasticity titration varies). Purpose: Decrease transient LES relaxations (reflux) and treat tone where present. Mechanism: Central GABA_B agonism; reduces excitatory neurotransmission. Side effects: Sedation, hypotonia, constipation; taper to avoid withdrawal. PubMed Central

6) Erythromycin (prokinetic, low-dose). Class: Macrolide bacterial infections. সহজ বাংলা: ব্যাকটেরিয়ার সংক্রমণের ওষুধ।" data-rx-term="antibiotic" data-rx-definition="An antibiotic is a medicine used to treat bacterial infections. সহজ বাংলা: ব্যাকটেরিয়ার সংক্রমণের ওষুধ।">antibiotic used as motilin agonist. Dose/time: ~1–3 mg/kg/dose 3–4×/day before meals (short courses). Purpose: Improve gastric emptying to reduce vomiting/aspiration risk. Mechanism: Motilin receptor agonism increases antral contractions. Side effects: GI cramps, QT risk, tachyphylaxis; avoid with interacting drugs. PubMed Central

7) Polyethylene glycol 3350 (PEG) for constipation. Class: Osmotic laxative. Dose/time: ~0.4–1 g/kg/day, titrate. Purpose: Soften stools, reduce pain/withholding, improve appetite. Mechanism: Non-absorbed polymer retains water in stool. Side effects: Bloating, diarrhea if overdosed. NCBI

8) Melatonin for sleep onset problems. Class: Chronobiotic/sedative-hypnotic supplement. Dose/time: Often 1–3 mg (start low) 30–60 min before bedtime; some need 3–5 mg; prolonged-release for maintenance. Purpose: Improve sleep onset and modestly total sleep time in neurodevelopmental disorders, paired with sleep hygiene. Mechanism: Reinforces circadian signaling via MT1/MT2 receptors. Side effects: Morning grogginess, pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">headache; long-term pediatric data limited—use under clinician guidance. BMJ+2PubMed+2

9) Levetiracetam for seizures (if present). Class: Antiseizure medication. Dose/time: Commonly starts ~10 mg/kg/day divided BID and titrates (per neurology). Purpose: Control seizures that worsen feeding/safety. Mechanism: SV2A modulation reduces synaptic neurotransmitter release. Side effects: Irritability, somnolence; monitor behavior. (General pediatric epilepsy practice; seizures occur in some ASXL3 children.) NCBI

10) Glycopyrrolate for drooling/aspiration risk. Class: Anticholinergic. Dose/time: ~0.02 mg/kg/dose TID; titrate. Purpose: Reduce sialorrhea that complicates feeding and airway safety. Mechanism: Blocks muscarinic receptors in salivary glands. Side effects: Dry mouth, constipation, urinary retention; balance with hydration and bowel plan. NCBI

I can add 10 more medications (e.g., cyproheptadine appetite modulation, magnesium hydroxide, senna, clonidine/guanfacine for sleep/behavior where appropriate, intraglandular botulinum toxin for drooling, etc.) with full 150-word mini-essays and citations—just say the word.


Dietary molecular supplements

Supplements should not replace feeding therapy or prescribed nutrition; quality varies and some interact with medicines. Use only with your clinician/dietitian. Here are 5 commonly discussed options; I can expand to 10 with longer entries.

1) Energy-dense modulars (MCT oil, carbohydrate powders, protein modules). Clinicians add small measured amounts to tolerated foods/formulas to raise calories without increasing volume, supporting catch-up growth. Monitor stools (MCT can loosen) and adjust with dietitian oversight. NCBI

2) Multivitamin/mineral supplement. When intake is limited or selective, a measured pediatric multivitamin closes common gaps (iron, vitamin D, zinc, B-group). Avoid megadoses; check labs if deficiency suspected. NCBI

3) Vitamin D (as indicated). Supports bone and immune health in children with reduced outdoor activity or low intake; dosing follows local pediatric guidance and serum levels. NCBI

4) Soluble fiber (e.g., inulin/psyllium) where textures allow. Can ease constipation and improve stool form when fluids are adequate; introduce slowly to limit gas. NCBI

5) Thickening agents (starch/xanthan-based), when recommended after swallow study. These modify liquid flow to reduce aspiration episodes and distress; professional guidance is essential to choose product and consistency. NCBI


Immunity booster / regenerative / stem-cell” drugs

At present there are no proven “regenerative” or stem-cell drugs that correct ASXL3 gene function or reverse the neurodevelopmental phenotype in children. Supportive, symptom-targeted care remains standard; families should be cautious about unregulated “stem-cell” claims marketed online. If you’d like, I can monitor registered clinical trials with you. NCBI+1


Surgeries and procedures

1) Gastrostomy tube (G-tube) placement. When oral intake is unsafe or insufficient despite optimized therapy and nutrition plans, a G-tube provides reliable calories, fluids, and medications, supporting growth and reducing mealtime stress. NCBI

2) Nissen fundoplication (with or without G-tube). Considered in selected children with severe, objectively proven GERD with complications (e.g., aspiration, esophagitis) who fail optimized medical/feeding management. It wraps the stomach fundus around the lower esophagus to reduce reflux. PubMed Central

3) Swallow/airway endoscopic evaluation and interventions. For recurrent aspiration or suspected structural problems, ENT/GI teams may perform endoscopic exams and targeted procedures guided by findings to improve safety. NCBI

4) Dental procedures under anesthesia for severe oral aversion/decay. Poor oral intake and reflux can increase dental issues; coordinated care reduces pain triggers that worsen feeding. NCBI

5) Feeding tube transitions (e.g., NG to G-tube) and later weaning. Temporary nasogastric tubes may start early; long-term needs often shift to a G-tube; with progress, structured weaning is possible under team guidance. NCBI


Practical preventions

  1. Keep a written feeding plan and update it after clinic visits. Team clarity prevents setbacks. NCBI

  2. Use safe seating and upright posture for all feeds; maintain for 20–30 min after. Medscape

  3. Prefer small, frequent feeds over large meals to limit reflux and fatigue. Medscape

  4. Follow a constipation plan (fiber/fluids/activity ± meds) to protect appetite and reflux control. NCBI

  5. Build consistent sleep routines before considering melatonin. BioMed Central

  6. Track growth and hydration at home (weights, wet diapers/urine frequency) and act early on changes. NCBI

  7. Keep vaccinations current to lower hospitalization risk. Team-based rare-disease care stresses prevention. National Organization for Rare Disorders

  8. Practice oral hygiene to reduce pain/aversion triggers and aspiration of oral bacteria. NCBI

  9. Learn choking/aspiration first aid; keep emergency numbers visible. peas.albertahealthservices.ca

  10. Vet supplements and “stem-cell” pitches with your clinicians to avoid harm and wasted cost. NCBI+1


When to see a doctor urgently vs routinely

Urgently: signs of dehydration (very low urine, lethargy), bloody or bilious vomiting, repeated choking/aspiration, abrupt weight loss, fever with poor intake, concerning nighttime breathing, or seizures. These can be serious and need prompt medical review. NCBI

Routinely: plateauing growth, persistent feeding distress, uncontrolled reflux/constipation, ongoing sleep problems despite hygiene measures, new behavioral feeding refusals, or caregiver burnout. Early adjustments in the plan can prevent hospitalization. NCBI


What to eat & what to avoid

What to prioritize: energy-dense, well-tolerated foods; smooth purées/soft textures that match skills; dietitian-guided fortification; adequate fluids; fiber sources compatible with your child’s plan; and balanced micronutrients via foods or a pediatric multivitamin if intake is limited. NCBI

What to limit/avoid: large, late meals; thin liquids if a study showed aspiration (use prescribed thickening); highly acidic/spicy foods that trigger reflux; constipating patterns without a bowel plan; and unregulated supplements that promise “regeneration.” Always personalize with your team. PubMed Central+1


FAQs

1) Is ASXL3-related disorder the same as Bainbridge-Ropers syndrome? Yes—Bainbridge-Ropers is the eponym; both mean ASXL3-related disorder. National Organization for Rare Disorders

2) Does it always cause microcephaly? Often, but not always. Phenotype is variable. NCBI

3) Why is feeding so hard? Low tone, oral-motor discoordination, reflux, sensory aversion, and constipation commonly interact. NCBI

4) Will a feeding tube be permanent? Not always. Some children transition off as skills and intake improve through therapy. NCBI

5) Are PPIs safe long-term? They help many children with documented GERD; prolonged use needs monitoring for infections and nutrient effects. Use the lowest effective dose and review regularly. PubMed Central

6) Is melatonin safe for sleep? Evidence supports benefit in neurodevelopmental disorders with good sleep hygiene, but pediatric long-term data are limited—use under clinical guidance. BMJ+2PubMed+2

7) Are there gene-targeted treatments? Not yet. Supportive, team-based care is current best practice. NCBI+1

8) How do we track progress? Regular weights/length or BMI-for-age, diet logs, symptom diaries, and therapy goals reviewed in clinic. NCBI

9) Who should be on our team? Primary care, genetics, GI, dietitian, SLP/OT, neurology (if seizures), ENT, dentistry, psychology/social work. NCBI

10) Can reflux get better? Many children improve with growth, therapy, and tailored dosing; some require procedures. PubMed Central

11) What about drooling? Positioning, oral-motor therapy, and medicines (e.g., glycopyrrolate) are options; discuss risks/benefits. NCBI

12) Do we need a swallow study? If there are choking/coughing, recurrent pneumonia, or suspected aspiration, an instrumental evaluation helps guide safety. NCBI

13) Are thickened liquids safe? When prescribed after an evaluation, they can reduce aspiration; product and consistency should be clinician-directed. NCBI

14) What sleep steps come before melatonin? Fixed schedule, light exposure, screen curfew, quiet routine, cool/dark room. BioMed Central

15) Where can we learn more and find support? GeneReviews, NORD, GARD, and ASXL foundations offer up-to-date resources and family connections. ARRE Foundation+3NCBI+3National Organization for Rare Disorders+3

Disclaimer: Each person’s journey is unique, treatment planlife stylefood habithormonal conditionimmune systemchronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 24, 2025.

  1. Rare Diseases and Medical Genetics.[rxharun.com]
  2. i2023_IFPMA_Rare_Diseases_Brochure_28Feb2017_FINAL.[rxharun.com]
  3. the-UK-rare-diseases-framework.[rxharun.com]
  4. National-Recommendations-for-Rare-Disease-Health-Care-Summary.[rxharun.com]
  5. History of rare diseases and their genetic.[rxharun.com]
  6. health-care-and-rare-disorders.[rxharun.com]
  7. Rare Disease Registries.[rxharun.com]
  8. autoimmune-Rare-Genetic-Diseases.[rxharun.com]
  9. Rare Genetic Diseases.[rxharun.com]
  10. rare-disease-day.[rxharun.com]
  11. Rare_Disease_Drugs_e.[rxharun.com]
  12. fda-CDER-Rare-Diseases-Public-Workshop-Master.[rxharun.com]
  13. rare-and-inherited-disease-eligibility-criteria.[rxharun.com]
  14. FDA-rare-disease-list.pdf-rxharun.com1 Human-Gene-Therapy-for-Rare Diseases_Jan_2020fda.[rxharun.com]
  15. FDA-rare-disease-lists.[rxharun.com]
  16. 30212783fnl_Rare Disease.[rxharun.com]
  17. FDA-rare-disease-list.[rxharun.com]
  18. List of rare disease.[rxharun.com]
  19. Genome Res.-2025-Steyaert-755-68.[rxharun.com]
  20. uk-practice-guidelines-for-variant-classification-v4-01-2020.[rxharun.com]
  21. PIIS2949774424010355.[rxharun.com]
  22. hidden-costs-2016.[rxharun.com]
  23. B156_CONF2-en.[rxharun.com]
  24. IRDiRC_State-of-Play-2018_Final.[rxharun.com]
  25. IRDR_2022Vol11No3_pp96_160.[rxharun.com]
  26. from-orphan-to-opportunity-mastering-rare-disease-launch-excellence.[rxharun.com]
  27. Rare disease fda.[rxharun.com]
  28. England-Rare-Diseases-Action-Plan-2022.[rxharun.com]
  29. SCRDAC 2024 Report.[rxharun.com]
  30. CORD-Rare-Disease-Survey_Full-Report_Feb-2870-2.[rxharun.com]
  31. Stats-behind-the-stories-Genetic-Alliance-UK-2024.[rxharun.com]
  32. rare-and-inherited-disease-eligibility-criteria-v2.[rxharun.com]
  33. ENG_White paper_A4_Digital_FINAL.[rxharun.com]
  34. UK_Strategy_for_Rare_Diseases.[rxharun.com]
  35. MalaysiaRareDiseaseList.[rxharun.com]
  36. EURORDISCARE_FULLBOOKr.[rxharun.com]
  37. EMHJ_1999_5_6_1104_1113.[rxharun.com]
  38. national-genomic-test-directory-rare-and-inherited-disease-eligibilitycriteria-.[rxharun.com]
  39. be-counted-052722-WEB.[rxharun.com]
  40. RDI-Resource-Map-AMR_MARCH-2024.[rxharun.com]
  41. genomic-analysis-of-rare-disease-brochure.[rxharun.com]
  42. List-of-rare-diseases.[rxharun.com]
  43. RDI-Resource-Map-AFROEMRO_APRIL[rxharun.com]
  44. rdnumbers.[rxharun.com] .
  45. Rare disease atoz .[rxharun.com]
  46. EmanPublisher_12_5830biosciences-.[rxharun.com]

  1. https://www.ncbi.nlm.nih.gov/books/NBK208609/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6279436/
  3. https://rarediseases.org/rare-diseases/
  4. https://rarediseases.info.nih.gov/diseases
  5. https://en.wikipedia.org/w/index.php?title=Category:Rare_diseases
  6. https://en.wikipedia.org/wiki/List_of_genetic_disorders
  7. https://en.wikipedia.org/wiki/Category:Genetic_diseases_and_disorders
  8. https://medlineplus.gov/genetics/condition/
  9. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  10. https://www.fda.gov/patients/rare-diseases-fda
  11. https://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/support-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-program
  12. https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2134
  13. https://www.mayoclinicproceedings.org/article/S0025-6196%2823%2900116-7/fulltext
  14. https://www.ncbi.nlm.nih.gov/mesh?
  15. https://www.rarediseasesinternational.org/working-with-the-who/
  16. https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03322-7
  17. https://www.rarediseasesnetwork.org/
  18. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-disease
  19. https://www.raregenomics.org/rare-disease-list
  20. https://www.astrazeneca.com/our-therapy-areas/rare-disease.html
  21. https://bioresource.nihr.ac.uk/rare
  22. https://www.roche.com/solutions/focus-areas/neuroscience/rare-diseases
  23. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  24. https://www.genomicsengland.co.uk/genomic-medicine/understanding-genomics/rare-disease-genomics
  25. https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
  26. https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026
  27. https://wikicure.fandom.com/wiki/Rare_Diseases
  28. https://www.wikidoc.org/index.php/List_of_genetic_disorders
  29. https://www.medschool.umaryland.edu/btbank/investigators/list-of-disorders/
  30. https://www.orpha.net/en/disease/list
  31. https://www.genetics.edu.au/SitePages/A-Z-genetic-conditions.aspx
  32. https://ojrd.biomedcentral.com/
  33. https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/rare-diseases_en
  34. https://bioportal.bioontology.org/ontologies/ORDO
  35. https://www.orpha.net/en/disease/list
  36. https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions
  37. https://www.gao.gov/products/gao-25-106774
  38. https://www.gene.com/partners/what-we-are-looking-for/rare-diseases
  39. https://www.genome.gov/For-Patients-and-Families/Genetic-Disorders
  40. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  41. https://my.clevelandclinic.org/health/diseases/21751-genetic-disorders
  42. https://globalgenes.org/rare-disease-facts/
  43. https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nord
  44. https://byjus.com/biology/genetic-disorders/
  45. https://www.cdc.gov/genomics-and-health/about/genetic-disorders.html
  46. https://www.genomicseducation.hee.nhs.uk/doc-type/genetic-conditions/
  47. https://www.thegenehome.com/basics-of-genetics/disease-examples
  48. https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
  49. https://www.pfizerclinicaltrials.com/our-research/rare-diseases
  50. https://clinicaltrials.gov/ct2/results?recrs
  51. https://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdf
  52. https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239
  53. https://www.nibib.nih.gov/
  54. https://www.nei.nih.gov/
  55. https://oxfordtreatment.com/
  56. https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/
  57. https://www.nccih.nih.gov/health
  58. https://catalog.ninds.nih.gov/
  59. https://www.aarda.org/diseaselist/
  60. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets
  61. https://www.nibib.nih.gov/
  62. https://www.nia.nih.gov/health/topics
  63. https://www.nichd.nih.gov/
  64. https://www.nimh.nih.gov/health/topics
  65. https://www.nichd.nih.gov/
  66. https://www.niehs.nih.gov/
  67. https://www.nimhd.nih.gov/
  68. https://www.nhlbi.nih.gov/health-topics
  69. https://obssr.od.nih.gov/.
  70. https://www.nichd.nih.gov/health/topics
  71. https://rarediseases.info.nih.gov/diseases
  72. https://beta.rarediseases.info.nih.gov/diseases
  73. https://orwh.od.nih.gov/

 

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Medicine doctor / pediatrician for children / qualified clinician
Tests to discuss with doctor
  • Temperature chart and hydration assessment
  • CBC with platelet count if fever persists or dengue/other infection is possible
  • Urine test, malaria/dengue tests, chest evaluation, or blood culture only when clinically indicated
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?
  • Do I need antibiotics, or is this more likely viral?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Severe Feeding Difficulties – Failure to Thrive – Microcephaly due to ASXL3 Deficiency

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.